Diakom, spol. s r.o.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Obesity1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Withdrawn1 trial

Lead sponsor

• Novo Nordisk A/S2 trials

Closed trials

• Withdrawn

  A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

  NCT07357740· Phase 2· Novo Nordisk A/S· Source

• Completed

  A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

  NCT05514535· Phase 3· Novo Nordisk A/S· Source